After the Fed released minutes of its last meeting, the bond market signaled it fears the Fed will not be aggressive enough with its rate cutting.Market Insiderread more
The Fed minutes also note that "a couple" members wanted a 50 basis point cut, based primarily on the weak inflation readings.The Fedread more
The inversion is seen by many veteran traders as an important recession omen, though the timing on the eventual downturn is less predictable.Bondsread more
Here's what Nordstrom reported for its fiscal second-quarter earnings.Retailread more
The sexy image that once boosted Victoria's Secret has been haunting L Brands more recently, as women are steering clear of the brand's hot pink, lacy and bejeweled lingerie.Retailread more
See which stocks are posting big moves after the bell.Market Insiderread more
"I'd love to say that the optimistic universe is most likely to prevail, but the talking heads talk endlessly about how a recession is inevitable," CNBC's Jim Cramer says.Mad Money with Jim Cramerread more
Read the fine print in your Apple Card contract — one clause means you give up your right to be heard in court.Technologyread more
Federal Reserve members worried over future growth are highly concerned about the U.S.-China tariff battleThe Fedread more
President Donald Trump signed a memorandum on Wednesday to automatically cancel the student loan debt of disabled veterans. More than 25,000 service members will have their...Personal Financeread more
President Trump and Apple CEO Tim Cook have had a rocky relationship in recent years, but Trump is now complimenting the executive publicly.Technologyread more
LONDON, Aug 9 (Reuters) - Bayer shares soared as much as 11% on Friday on a Bloomberg report that the German company has proposed to pay $8 billion to settle more than 18,000 U.S. lawsuits on its glyphosate-based weedkiller Roundup case.
The stock was on track for its best single-day gain in a decade as traders said the settlement could remove an "overhang" on Bayer shares.
Bayer shares have lost more than a third, or roughly 30 billion euros ($33.56 billion), in market value since August last year, when a California jury in the first such lawsuit found that Monsanto should have warned of the alleged cancer risks.
A Bayer spokesman declined to comment.
At 0813 GMT, the shares were up 8.7% at 68.5 euros, the top gainer on Germany's blue chip DAX 30 index.
($1 = 0.8941 euros) (Reporting by Thyagaraju Adinarayan; additional reporting by Ludwig Burger; editing by Josephine Mason)